Scott Reents is the Executive Vice President and Chief Financial Officer at AbbVie, where he is responsible for the companys global financial and business technology operations. His background includes roles at Abbott, Pfizer, and Deloitte. He holds a Juris Doctor and an MBA from Washington University in St. Louis.
Outside of his corporate responsibilities, Scott is engaged with his alma maters, the University of Nebraska and Washington University. He is also a member of the Board of Trustees for the Ravinia Festival, an orchestral music festival in Illinois, reflecting an interest in the performing arts.
He holds both a Juris Doctor and an MBA, a combination of legal and business expertise that is distinctive for a Chief Financial Officer.
Scott Reents
Executive Vice President, Chief Financial Officer at AbbVie
North Chicago, Illinois, United States
Overview
Topics They Care About
Financial Strategy
As CFO, he frequently discusses AbbVie's financial performance, company growth, and strategies for navigating market changes like patent expirations during investor calls and industry conferences.
AI in Business
He has led internal AI Summits at AbbVie to explore how the company can further embrace and tap into artificial intelligence to drive growth and innovation.
Organizational Leadership
He focuses on developing principles of focus, connectivity, and support within his Finance and Business Technology Solutions organization to drive AbbVie’s growth.
Media Appearances
Scott has no verified media appearances
Work History
11-2022
Executive Vice President, Chief Financial Officer at AbbVie
6-2022 - 12-2022
Senior Vice President, Chief Financial Officer at AbbVie
3-2019 - 6-2022
Vice President, Tax and Treasury at AbbVie
Education
1990 - 1994
Juris Doctor from Washington University in St. Louis
1990 - 1994
Master of Business Administration (MBA) from Washington University in St. Louis
More Information
Social Presence :
Prographics :
Exp : 6
Location : North Chicago, Illinois, United States
Job Level : Leadership
Designation : Executive Vice President, Chief Financial Officer at AbbVie
